Here's the live share price of FDC along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of FDC has gained 6.39% CAGR. Over the past year, the corresponding return has been -15.25%.
FDC’s current P/E of 27.93x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| FDC | 7.32 | 1.12 | -3.45 | 9.15 | -15.25 | 13.95 | 6.39 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, FDC has declined 15.25% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, FDC has underperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 436.02 | 441.53 |
| 10 | 436.1 | 440.73 |
| 20 | 444.6 | 444.69 |
| 50 | 458.93 | 454.81 |
| 100 | 469.36 | 459.44 |
| 200 | 451.71 | 461.45 |
In the latest quarter, FDC remained same as its previous close in promoter holding, while DII stake decreased to 6.81%, FII holding rose to 2.43%, and public shareholding moved up to 21.10% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 42,75,331 | 0.29 | 189.1 | |
| 19,26,874 | 1.01 | 85.23 | |
| 11,97,689 | 0.85 | 52.97 | |
| 7,85,551 | 0.22 | 34.74 | |
| 6,28,365 | 2.14 | 27.79 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Oct 28, 2025, 9:58 PM IST | FDC - Board Meeting Intimation for Unaudited Standalone & Consolidated Financial Results For Quarter And Half Year Ended On S |
| Oct 17, 2025, 11:20 PM IST | FDC - Announcement under Regulation 30 (LODR)-Change in Management |
| Oct 08, 2025, 5:57 AM IST | FDC - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 04, 2025, 10:58 PM IST | FDC - Announcement Under Regulation 30-LODR (Intimation On ANDA Approval) |
| Sep 26, 2025, 11:16 PM IST | FDC - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
FDC Ltd. is a Public Limited Listed company incorporated on 23/09/1940 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1940PLC003176 and registration number is 003176. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 2070.11 Cr. and Equity Capital is Rs. 16.28 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for FDC is ₹461.70 as on Oct 31, 2025.
The FDC is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of FDC is ₹7,516.94 Cr as on Oct 31, 2025.
Today’s highest and lowest price of FDC are ₹465.00 and ₹450.80.
The 52-week high/low is the highest and lowest price at which FDC stock has traded in the past 52-week or nearly a year. The 52-week high of FDC is ₹559.00 and 52-week low of FDC is ₹358.95 as on Oct 31, 2025.
The FDC has shown returns of 2.17% over the past day, 1.12% for the past month, -3.45% over 3 months, -15.25% over 1 year, 13.95% across 3 years, and 6.39% over 5 years.
P/E ratio of and PB ratio of FDC are 27.93 and 3.30 on Oct 31, 2025. While the company gives a dividend yield of 1.08 per annum.